Serum low-density lipoprotein and high-density lipoprotein cholesterol, and liver size in subjects on drugs inducing hepatic microsomal enzymes P. V. LuomaE. A. SotaniemiH. I. Pirttiaho Originals Pages: 615 - 618
Correlation between plasma levels of fenofibrate and lipoprotein changes in hyperlipidaemic patients C. R. SirtoriG. MontanariE. Bosisio Originals Pages: 619 - 624
Prospective study of the potentiation of acenocoumarol by amiodarone C. RichardB. RiouP. Auzépy Originals Pages: 625 - 629
Bronchorelaxation and plasma histamine after salbutamol inhalation I. MacquinA. HarfF. Lhoste Originals Pages: 631 - 636
Antisecretory effect and oral pharmacokinetics of omeprazole in patients with chronic renal failure C. W. HowdenC. D. PaytonJ. A. H. Forrest Originals Pages: 637 - 640
Acute and subacute effects on psychomotor performance of femoxetine alone and with alcohol C. StrömbergM. J. Mattila Originals Pages: 641 - 647
Bioavailability of the bis- and monodigitoxosides of digitoxigenin P. E. FensterR. T. MacFarlandF. I. Marcus Originals Pages: 649 - 652
Plasma levels and myocardial content of verapamil, norverapamil and two N-dealkyl-metabolites in man R. PadriniE. BarbieriM. Ferrari Originals Pages: 653 - 657
The pharmacokinetics and haemodynamics of BTS 49465 and its major metabolite in healthy volunteers R. D. WynneE. L. CramptonI. D. Hind Originals Pages: 659 - 664
Pharmacokinetics of tocainide in patients with severe renal failure J. BraunF. SörgelU. Geßler Originals Pages: 665 - 670
Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamide U. KlotzP. ArvelaB. Rosenkranz Originals Pages: 671 - 675
Effect of nifedipine on gastric acid secretion and gastrin release in healthy man R. CaldaraE. MasciA. Tittobello Originals Pages: 677 - 679
Influence of cimetidine on steady state concentration and metabolite formation from antipyrine infused with a rectal osmotic mini pump M. W. E. TeunissenC. H. KleinbloesemD. D. Breimer Originals Pages: 681 - 684
Effects of a stable prostaglandin analogue, L-644,122, in healthy and hypertensive men J. M. RitterJ. R. LudginM. J. Dunn Originals Pages: 685 - 688
Factors affecting the kinetics of two benzothiazine non-steroidal anti-inflammatory medicines, piroxicam and isoxicam I. R. EdwardsD. G. FerryA. J. Campbell Originals Pages: 689 - 692
Plasma protein binding of imipramine in patients with rheumatoid arthritis C. B. Kristensen Originals Pages: 693 - 696
Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics L. GroopE. Wåhlin-BollF. Fyhrqvist Originals Pages: 697 - 704
The effect of a 1-deoxynojirimycin derivative on post-prandial blood glucose and insulin levels in healthy black and white volunteers P. H. JoubertC. P. VenterI. Hillebrand Originals Pages: 705 - 708
Antihypertensive therapy with a single daily dose of acebutolol in essential hypertension, response and ophthalmological assessment in the Japanese K. SekineM. TakahashiM. Takase Short Communications Pages: 709 - 711
Double blind study of the influence of co-dergocrine on platelet parameters in healthy volunteers H. Sinzinger Short Communications Pages: 713 - 716
Effect of guar gum on glipizide absorption in man R. HuupponenS. KarhuvaaraP. Seppälä Short Communications Pages: 717 - 719
Further support for changes in chloroquine disposition and metabolism between a low and a high dose M. Frisk-HolmbergY. BergqvistE. Termond Short Communications Pages: 721 - 722
Dosage schedules for chloroquine P. I. PillansJ. L. StraughanMarianne Frisk-Holmberg Letter To The Editors Pages: 723 - 723
D-propoxyphene: Accumulation or altered kinetics? W. A. ColburnC. E. InturrisiL. F. Gram Letter To The Editors Pages: 725 - 726
